ID29818A - Penggunaan antagonis reseptor angiotensin ii untuk mengobati infarksi miokardial - Google Patents
Penggunaan antagonis reseptor angiotensin ii untuk mengobati infarksi miokardialInfo
- Publication number
- ID29818A ID29818A IDW00200101602A ID20011602A ID29818A ID 29818 A ID29818 A ID 29818A ID W00200101602 A IDW00200101602 A ID W00200101602A ID 20011602 A ID20011602 A ID 20011602A ID 29818 A ID29818 A ID 29818A
- Authority
- ID
- Indonesia
- Prior art keywords
- angiotensin
- treat
- receptor antagonists
- miocardial infarction
- acute
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99810061 | 1999-01-26 | ||
US46866499A | 1999-12-21 | 1999-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID29818A true ID29818A (id) | 2001-10-11 |
Family
ID=26153740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW00200101602A ID29818A (id) | 1999-01-26 | 2000-01-24 | Penggunaan antagonis reseptor angiotensin ii untuk mengobati infarksi miokardial |
Country Status (25)
Country | Link |
---|---|
EP (2) | EP1714651A1 (zh) |
JP (1) | JP2002535367A (zh) |
KR (1) | KR100674053B1 (zh) |
CN (1) | CN1337879A (zh) |
AT (1) | ATE330599T1 (zh) |
AU (1) | AU766453C (zh) |
BR (1) | BR0007686A (zh) |
CA (1) | CA2360691A1 (zh) |
CY (1) | CY1105257T1 (zh) |
CZ (1) | CZ20012682A3 (zh) |
DE (1) | DE60028928T2 (zh) |
DK (1) | DK1146872T3 (zh) |
ES (1) | ES2265910T3 (zh) |
HK (1) | HK1041808B (zh) |
HU (1) | HUP0105199A3 (zh) |
ID (1) | ID29818A (zh) |
IL (2) | IL144216A0 (zh) |
NO (1) | NO20013459L (zh) |
NZ (1) | NZ513039A (zh) |
PL (1) | PL197161B1 (zh) |
PT (1) | PT1146872E (zh) |
RU (2) | RU2298405C2 (zh) |
SI (1) | SI1146872T1 (zh) |
SK (1) | SK10522001A3 (zh) |
WO (1) | WO2000044378A1 (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR200805275T2 (tr) | 1998-12-23 | 2008-09-22 | Novartis Ag | AT-1 veya AT-2 reseptörlerindeki artışın neden olduğu hastalıkların tedavisi için AT-1 reseptör antagonisti veya AT-2 reseptör modülatörünün kullanımı@ |
CA2420844A1 (en) * | 2000-08-30 | 2003-02-28 | Sankyo Company, Limited | Medicinal compositions for preventing or treating heart failure |
US7076287B2 (en) | 2000-12-29 | 2006-07-11 | Ge Medical Systems Information Technologies, Inc. | System and method for detecting new left bundle branch block for accelerating treatment of acute myocardial infarction |
JP2005509631A (ja) * | 2001-10-18 | 2005-04-14 | ノバルティス アクチエンゲゼルシャフト | At1−レセプターアンタゴニストと心臓血管薬から形成される塩 |
EG24716A (en) | 2002-05-17 | 2010-06-07 | Novartis Ag | Combination of organic compounds |
MXPA04011428A (es) * | 2002-05-17 | 2005-02-14 | Novartis Ag | Combinacion de bloqueador del receptor de angiotensina ii y bloqueador-beta para la prevencion secundaria de infarto de miocardio. |
SE0302331D0 (sv) * | 2003-08-29 | 2003-08-29 | Astrazeneca Ab | New use II |
WO2005030202A1 (en) * | 2003-09-26 | 2005-04-07 | Novartis Ag | Use of angiotensin ii receptor antagonists for treating cerebrovascular disorders |
WO2005053687A1 (en) * | 2003-11-25 | 2005-06-16 | Novartis Ag | Combination of organic compounds |
WO2009087116A1 (en) * | 2008-01-11 | 2009-07-16 | Novartis Ag | Use of spp100 for the treatment of acute mi |
CN104086623B (zh) * | 2014-07-02 | 2017-05-24 | 牡丹江友搏药业有限责任公司 | 一种新的具有降压和细胞保护作用的化合物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9027208D0 (en) * | 1990-12-14 | 1991-02-06 | Smithkline Beecham Plc | Medicaments |
EP0577025A3 (de) * | 1992-07-01 | 1998-02-04 | Hoechst Aktiengesellschaft | Angiotensin-II-Rezeptorantagonisten zur Behandlung und Prophylaxe von koronaren Herzerkrankungen |
FR2716882B1 (fr) * | 1994-03-04 | 1996-04-05 | Roussel Uclaf | Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques. |
DE4432860A1 (de) * | 1994-09-15 | 1996-03-21 | Merck Patent Gmbh | Imidazopyridine |
GB9613470D0 (en) * | 1996-06-27 | 1996-08-28 | Ciba Geigy Ag | Small solid oral dosage form |
US5795904A (en) * | 1996-12-06 | 1998-08-18 | Merck & Co., Inc. | Enhanced functional recovery of the heart by losartan treatment after an ischemic attach |
-
2000
- 2000-01-24 KR KR1020017009327A patent/KR100674053B1/ko not_active IP Right Cessation
- 2000-01-24 CZ CZ20012682A patent/CZ20012682A3/cs unknown
- 2000-01-24 BR BR0007686-4A patent/BR0007686A/pt not_active Application Discontinuation
- 2000-01-24 DE DE60028928T patent/DE60028928T2/de not_active Revoked
- 2000-01-24 PT PT00902628T patent/PT1146872E/pt unknown
- 2000-01-24 ID IDW00200101602A patent/ID29818A/id unknown
- 2000-01-24 JP JP2000595681A patent/JP2002535367A/ja not_active Withdrawn
- 2000-01-24 RU RU2001122113/15A patent/RU2298405C2/ru not_active IP Right Cessation
- 2000-01-24 HU HU0105199A patent/HUP0105199A3/hu unknown
- 2000-01-24 SK SK1052-2001A patent/SK10522001A3/sk not_active Application Discontinuation
- 2000-01-24 AT AT00902628T patent/ATE330599T1/de not_active IP Right Cessation
- 2000-01-24 CA CA002360691A patent/CA2360691A1/en not_active Abandoned
- 2000-01-24 AU AU24397/00A patent/AU766453C/en not_active Ceased
- 2000-01-24 PL PL349537A patent/PL197161B1/pl not_active IP Right Cessation
- 2000-01-24 WO PCT/EP2000/000525 patent/WO2000044378A1/en active Application Filing
- 2000-01-24 EP EP06009525A patent/EP1714651A1/en not_active Withdrawn
- 2000-01-24 NZ NZ513039A patent/NZ513039A/en unknown
- 2000-01-24 CN CN00803157A patent/CN1337879A/zh active Pending
- 2000-01-24 ES ES00902628T patent/ES2265910T3/es not_active Expired - Lifetime
- 2000-01-24 EP EP00902628A patent/EP1146872B1/en not_active Revoked
- 2000-01-24 SI SI200030891T patent/SI1146872T1/sl unknown
- 2000-01-24 IL IL14421600A patent/IL144216A0/xx active IP Right Grant
- 2000-01-24 DK DK00902628T patent/DK1146872T3/da active
-
2001
- 2001-07-09 IL IL144216A patent/IL144216A/en not_active IP Right Cessation
- 2001-07-12 NO NO20013459A patent/NO20013459L/no not_active Application Discontinuation
-
2002
- 2002-02-22 HK HK02101372.4A patent/HK1041808B/zh not_active IP Right Cessation
-
2006
- 2006-09-07 CY CY20061101283T patent/CY1105257T1/el unknown
- 2006-10-05 RU RU2006135205/15A patent/RU2345790C2/ru not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1105257T1 (el) | Χρηση των ανταγωνιστων των υποδοχεων της αγγειοτενσινης ii στην θepαπεια του οξεος εμφραγματος του μυοκαρδιου | |
CY1106697T1 (el) | Ν-υποκατεστημενες υδρομορφονες και η χρηση αυτων | |
DK1588706T3 (da) | Valsartantablet | |
NO963064L (no) | Behandling av normotensive glaukoma med angiotensin-II-antagonister | |
CY1106365T1 (el) | Συνδυασμος ενος αναστολεα pde και ενος ανταγωνιστη υποδοχεων λευκοτριενιου | |
MXPA03009595A (es) | Uso de antagonistas del canal de sodio neuronal para control de ectoparasitos de animales homeotermicos. | |
ATE295183T1 (de) | Mittel zur linderung von juckreiz, enthaltend pgd2- antagonisten | |
RS78004A (en) | Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist | |
IL145645A0 (en) | N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists | |
AP2002002501A0 (en) | Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog. | |
MY135441A (en) | Therapeutic treatment | |
BR0000486A (pt) | Antagonistas do neuropeptìdeo y | |
PT896822E (pt) | 4-aminopirrolo (3,2-d)pirimidinas como antagonistas do receptor de neuropeptideo y | |
EA200401617A1 (ru) | Комбинация nmda-антагониста и ингибиторов ацетилхолинэстеразы для лечения болезни альцгеймера | |
BR0311881A (pt) | Combinações de inbidores de pde-v e antagonistas de nk1 para o tratamento de depressão | |
NO981188D0 (no) | 5-HT3-reseptorantagonister for dyskinesi | |
EP1095655A3 (en) | NK-1 receptor antagonists and eletriptan for the treatment of migraine |